New Delhi: National drug pricing regulator NPPA on Monday said it has notified prices of 65 essential formulations, including those used for the treatment of diabetes, infections, pain and high blood pressure. "NPPA has fixed/revised ceiling prices/Retail Prices of 65 scheduled formulations under Drugs (Prices Control) Order, 2013," it said. NPPA fixes ceiling price of essential medicines of Schedule I under the Drugs (Prices Control) Order (DPCO) 2013.
In respect of medicines that are not under price control, manufacturers are allowed to increase the maximum retail price by 10 per cent annually.
The calculation for essential drugs is based on the simple average of all medicines in a particular therapeutic segment with sales of more than 1 per cent.
Since 1997, NPPA has been entrusted with the task of fixation/revision of prices of pharma products, enforcement of DPCO and monitoring of prices of controlled and decontrolled drugs.